CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock
CalAmp Corp. (CAMP)
Last calamp corp. earnings: 12/19 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.calamp.com/home/default.aspx
Company Research
Source: GlobeNewswire
CAMBRIDGE, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or the “Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels to treat a broad range of genetic diseases, today announced the pricing of its underwritten offering of 5,000,000 shares of its common stock at a price of $6.00 per share. The gross proceeds to the Company from this offering are expected to be $30.0 million, before deducting underwriting discounts and commissions and other offering expenses. The offering is expected to close on or about December 19, 2025, subject to satisfaction of customary closing conditions. All of the securities to be sold in the offering are being offered by the Company. CAMP4 currently anticipates using the net proceeds from the offering, together with its existing cash, cash equivalents and m
Show less
Read more
Impact Snapshot
Event Time:
CAMP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CAMP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CAMP alerts
High impacting CalAmp Corp. news events
Weekly update
A roundup of the hottest topics
CAMP
News
- CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic DiscoveriesGlobeNewswire
- CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- CAMP4 Reports Third Quarter 2025 Financial Results and Corporate HighlightsGlobeNewswire
- CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01GlobeNewswire
CAMP
Earnings
- 3/28/25 - Miss
CAMP
Analyst Actions
- 10/2/25 - Cantor Fitzgerald